Ferguson, Ian D.
PatiƱo-Escobar, Bonell http://orcid.org/0000-0003-2622-4822
Tuomivaara, Sami T. http://orcid.org/0000-0002-7150-0665
Lin, Yu-Hsiu T. http://orcid.org/0000-0002-7157-4330
Nix, Matthew A.
Leung, Kevin K. http://orcid.org/0000-0002-2087-4974
Kasap, Corynn
Ramos, Emilio
Nieves Vasquez, Wilson http://orcid.org/0000-0003-0423-4472
Talbot, Alexis http://orcid.org/0000-0001-6734-413X
Hale, Martina
Naik, Akul
Kishishita, Audrey
Choudhry, Priya
Lopez-Girona, Antonia
Miao, Weili http://orcid.org/0000-0002-7487-8962
Wong, Sandy W.
Wolf, Jeffrey L.
Martin, Thomas G. III
Shah, Nina
Vandenberg, Scott
Prakash, Sonam
Besse, Lenka
Driessen, Christoph
Posey, Avery D. Jr. http://orcid.org/0000-0001-8711-629X
Mullins, R. Dyche http://orcid.org/0000-0002-0871-5479
Eyquem, Justin http://orcid.org/0000-0001-8262-1190
Wells, James A. http://orcid.org/0000-0001-8267-5519
Wiita, Arun P. http://orcid.org/0000-0002-7465-6964
Funding for this research was provided by:
Gabrielle's Angel Foundation for Cancer Research
Article History
Received: 23 November 2020
Accepted: 30 June 2022
First Online: 15 July 2022
Competing interests
: A.P.W. is a member of the Scientific Advisory Board and holds equity stakes in Indapta Therapeutics and Protocol Intelligence, LLC. J.A.W. is on the Scientific Advisory Board and holds equity stakes in the following companies with oncology interests: Soteria Biotherapeutics, Jnana Therapeutics, Inception Therapeutics, and Inzen Therapeutics, and holds a sponsored research agreement with Bristol Myers Squibb. S.W.W. has received research funding from Janssen, GlaxoSmithKline, Bristol Myers Squibb, Genentech, and Fortis, and served as a consultant to Amgen. T.G.M. has received research funding from Sanofi, Janssen, and Amgen and has served as a consultant to GlaxoSmithKline. A.L.-G. is an employee and shareholder of Celgene/Bristol Myers Squibb. P.C. is currently an employee and shareholder of Roche/Genentech but was solely employed by UCSF during her participation on this project. A.D.P. is on the Scientific Advisory Board of Astellas Pharma, GO Therapeutics, and Stromatis Pharma, holds equity stakes in Stromatis Pharma, and received research funding from Tmunity Therapeutics. J.E. is a co-founder and holds an equity stake in Mnemo Therapeutics. The other authors declare no conflicts of interest.